Comment from Lifeloc Technologies Inc.

Summary: Lifeloc Technologies Inc., a manufacturer of alcohol breathalyzers and drug testing equipment, supports the FDA's proposal to exempt certain Class II devices from the premarket 510(k) notification process. The company argues that this change will reduce costly regulatory hurdles and benefit smaller companies by accelerating the commercialization of testing devices.